Advanced therapy manufacturing and automation experts, Scinogy, join the CRC for Cell Therapy Manufacturing (CTM CRC) to accelerate development of next gen cell therapy manufacturing.

The CRC for Cell Therapy Manufacturing (CTM CRC) is an international collaboration of 16 participant organisations spanning industry, clinicians, healthcare and research providers.

A $60M investment from the Australian Government and CTM CRC’s participants enables CTM CRC to connect cell biology with advanced materials in a unique approach to address the challenges in regenerative medicine today. Through this, CTM CRC is developing integrated solutions for cost effective, accessible cell therapies